Mohamad A Cherry

Contact Information:
Mohamad A Cherry



 

Cherry, Mohamad A. (HSC)
Faculty

Department of:

College Of Medicine/Medicine Hematology/Oncology -Assistant Professor

Center of:

Peggy & Charles Stephenson Oklahoma Cancer Center -

Education:

Lebanese University- Faculty of Medical Sciences   Medical Doctor   2001
Sacre Coeur Hospital-Lebanese University   Internal Medicine Internship   2002
American University of Beirut Medical Center   Internal Medicine Residency   2003
Staten Island University Hospital   Internal Medicine Residency   2006
Oklahoma University Health Sciences Center   Hematology/Oncology Fellow   2010

Professional Interest/Expertise/Specializations:
Leukemia Sarcoma Lymphoma Blood Disorders

Websites:

Research Projects:

Selected Publications:

1. Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera - single center experience.
2015    Masarova L, Cherry M, Newberry KJ, Estrov Z, Cortes JE, Kantarjian HM, Verstovsek S.
Leukemia Lymphoma.
http://www.ncbi.nlm.nih.gov/pubmed/25904378
Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia.
2015    Srour SA, Borders EB, Cherry MA, Holter J, Herman T, Selby GB.
Leukemia Lymphoma
http://www.ncbi.nlm.nih.gov/pubmed/?term=Role+of+topotecan%2C+vinorelbine%2C+thiotepa+and+gemcitabine+chemotherapy+in+relapsed%2Frefractory+adult+acute+leukemia.
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
2014    Cherry M, Khawandanah M, Zhao ZJ, Srour S, Ozer H, Selby G, Ghabache B, Al-Kali A
Ann Hematol.